OPPORTUNITIES FOR IMPROVING THE DRUG DEVELOPMENT PROCESS: RESULTS FROM A SURVEY OF INDUSTRY AND THE FDA
Year of publication: |
2005
|
---|---|
Authors: | Berndt, Ernst R. ; Gottschalk, Adrian H.B. ; Strobeck, Matthew W. |
Published in: |
Working paper / National Bureau of Economic Research, Inc. - Cambridge, Mass, ISSN 0898-2937, ZDB-ID 12239057. - 2005, 11425
|
Saved in:
Saved in favorites
Similar items by person
-
ASSESSING THE SAFETY AND EFFICACY OF THE FDA: THE CASE OF THE PRESCRIPTION DRUG USER FEE ACTS
Philipson, Tomas J., (2005)
-
Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
Philipson, Tomas, (2008)
-
Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
Philipson, Tomas, (2008)
- More ...